A. Lopez, K. Shibuya, C. Rao, C. Mathers, A. Hansell et al., Chronic obstructive pulmonary disease: current burden and future projections, European Respiratory Journal, vol.27, issue.2, pp.397-412, 2006.
DOI : 10.1183/09031936.06.00025805

URL : http://www.zora.uzh.ch/36471/1/Lopez_et_al_2006.pdf

H. Gunen, S. Hacievliyagil, F. Kosar, L. Mutlu, G. Gulbas et al., Factors affecting survival of hospitalised patients with COPD, European Respiratory Journal, vol.26, issue.2, pp.234-241, 2005.
DOI : 10.1183/09031936.05.00024804

J. Lightowler, J. Wedzicha, M. Elliott, and F. Ram, Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis, BMJ, vol.326, issue.7382, p.185, 2003.
DOI : 10.1136/bmj.326.7382.185

G. Gursel, Determinants of the Length of Mechanical Ventilation in Patients with COPD in the Intensive Care Unit, Respiration, vol.72, issue.1, pp.61-67, 2005.
DOI : 10.1159/000083402

A. Khanna and N. Kurtzman, Metabolic alkalosis, Respir Care, vol.46, pp.354-365, 2001.

P. Berthelsen, I. Gøthgen, B. Husum, and E. Jacobsen, Oxygen uptake and carbon dioxide elimination after acetazolamide in the critically ill, Intensive Care Medicine, vol.11, issue.1, pp.26-29, 1985.
DOI : 10.1007/BF00256061

S. Brimioulle, J. Berre, P. Dufaye, J. Vincent, J. Degaute et al., Hydrochloric acid infusion for treatment of metabolic alkalosis associated with respiratory acidosis, Critical Care Medicine, vol.17, issue.3, pp.232-236, 1989.
DOI : 10.1097/00003246-198903000-00006

E. Swenson, Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression, European Respiratory Journal, vol.12, issue.6, pp.1242-1247, 1998.
DOI : 10.1183/09031936.98.12061242

J. Mazur, J. Devlin, M. Peters, M. Jankowski, M. Iannuzzi et al., Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients, Critical Care Medicine, vol.27, issue.7, pp.1257-1261, 1999.
DOI : 10.1097/00003246-199907000-00004

C. Faisy, A. Mokline, O. Sanchez, J. Tadié, and J. Fagon, Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation, Intensive Care Medicine, vol.163, issue.5, pp.859-863, 2010.
DOI : 10.1007/s00134-010-1795-7

K. Rabe, S. Hurd, A. Anzueto, P. Barnes, S. Buist et al., Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.6, pp.532-555, 2007.
DOI : 10.1164/rccm.200703-456SO

J. Boles, J. Bion, A. Connors, M. Herridge, B. Marsh et al., Weaning from mechanical ventilation, European Respiratory Journal, vol.29, issue.5, pp.1033-1056, 2007.
DOI : 10.1183/09031936.00010206

L. Gall, J. Lemeshow, S. Saulnier, and F. , A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-2963, 1993.
DOI : 10.1001/jama.270.24.2957

I. Yano, A. Takayama, M. Takano, M. Inatani, H. Tanihara et al., Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation, European Journal of Clinical Pharmacology, vol.54, issue.1, pp.63-68, 1998.
DOI : 10.1007/s002280050422

. Heming, Critical Care, p.213, 2011.

W. Ritschel, C. Paulos, A. Arancibia, M. Agrawal, K. Wetzelsberger et al., Pharmacokinetics of Acetazolamide in Healthy Volunteers after Short- and Long-Term Exposure to High Altitude, The Journal of Clinical Pharmacology, vol.48, issue.6, pp.533-539, 1998.
DOI : 10.1002/j.1552-4604.1998.tb05791.x

R. Ihaka and R. Gentleman, R: a language for data analysis and graphics, J Comput Graphic Stat, vol.5, pp.299-314, 1996.

P. Berthelsen, I. Gøthgen, B. Husum, and E. Jacobsen, DISSOCIATION OF RENAL AND RESPIRATORY EFFECTS OF ACETAZOLAMIDE IN THE CRITICALLY ILL, BJA: British Journal of Anaesthesia, vol.58, issue.5, pp.512-516, 1986.
DOI : 10.1093/bja/58.5.512

L. Teppema and A. Dahan, Acetazolamide and Breathing, American Journal of Respiratory and Critical Care Medicine, vol.160, issue.5, pp.1592-1597, 1999.
DOI : 10.1164/ajrccm.160.5.9903088

H. Kiwull-schöne, L. Teppema, and P. Kiwull, Low-dose Acetazolamide Does Affect Respiratory Muscle Function in Spontaneously Breathing Anesthetized Rabbits, American Journal of Respiratory and Critical Care Medicine, vol.163, issue.2, pp.478-483, 2001.
DOI : 10.1164/ajrccm.163.2.9911075

M. Wagenaar, L. Teppema, A. Berkenbosch, C. Olievier, and H. Folgering, The effect of low-dose acetazolamide on the ventilatory CO2 response curve in the anaesthetized cat., The Journal of Physiology, vol.495, issue.1, pp.227-237, 1996.
DOI : 10.1113/jphysiol.1996.sp021587

N. Webster and V. Kulkarni, Metabolic Alkalosis in the Critically III, Critical Reviews in Clinical Laboratory Sciences, vol.121, issue.5, pp.497-510, 1999.
DOI : 10.1164/ajrccm/141.5_Pt_1.1185

Y. Uway, H. Saito, Y. Hashimoto, and K. Inui, Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1, J Pharmacol Exp Ther, vol.295, pp.261-265, 2000.

T. Maren, Chemistry of the Renal Reabsorption of Bicarbonate, Canadian Journal of Physiology and Pharmacology, vol.52, issue.6, pp.1041-1050, 1974.
DOI : 10.1139/y74-138

T. Maren, Carbonic anhydrase: chemistry, physiology, and inhibition, Physiol Rev, vol.47, pp.595-781, 1967.

P. Preisig, R. Toto, and R. Alpern, Carbonic Anhydrase Inhibitors, Kidney and Blood Pressure Research, vol.10, issue.3-4, pp.136-159, 1987.
DOI : 10.1159/000173126

K. Groenewegen, A. Scholas, and E. Wouters, Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD*, Chest, vol.124, issue.2, pp.459-467, 2003.
DOI : 10.1378/chest.124.2.459